The American Medical Association (AMA) recently released a free tool to help clinical staff determine appropriate CPT® and HCPCS Level II coding for COVID-19 vaccines and vaccine administration.
Correct coding for diseases of the blood can be difficult due to the lack of official guidance and the complexity of diagnosis. Clear up confusion by taking a closer look at these codes.
Section 1862 (l) and Section 1869 (f)(2)(B) of the Social Security Act (the Act) sets forth general procedures to develop and evaluate Medicare coverage determinations that are either adopted nationally by CMS or created and applied locally by a Medicare Administrative Contractor (MAC) within the MAC’s own jurisdictional boundaries.
CMS recently released MLN Matters MM12126, which summarizes 2021 CPT and HCPCS Level II code updates for Part B outpatient therapy services. The changes permanently expand Medicare coverage of certain communication technology-based (CTB) services, including virtual check-ins and telephone assessments.
This article details 2021 updates to CPT® codes for medicine services including several new codes for continuous electrocardiogram (ECG) recordings and auditory-evoked potentials (AEP), as well as American Medical Association (AMA)-approved CPT codes for COVID-19 immunizations.
In a year of unprecedented disruption and uncertainty, coding productivity managed to hold steady, according to the results of HIM Briefings’ 2020 Coding Productivity Survey. Learn how facilities adapted and how yours compares.
The HIM department plays a critical role in the revenue cycle, but it’s often placed in a reactive position, limiting its effectiveness. Learn how to improve operations by enhancing the HIM department’s involvement across the revenue cycle.
The American Medical Association (AMA) recently updated the CPT code set to include immunization and administration codes for a COVID-19 vaccine under development by AstraZeneca and the University of Oxford.
CMS recently released two new HCPCS Level II codes for Regeneron’s antibody drugs casirivimab and imdevimab, effective for dates of service on or after November 21. The creation of the new codes comes in response to the Food and Drug Administration issuance of an emergency use authorization for the drug therapies on November 9.
